A Search Service for Abbreviation / Long Form

â–  Abbreviation / Long Form : EC / endometrial cancer

[Related PubMed/MEDLINE]
Total Number of Papers: 1037
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   EC  (>> Co-occurring Abbreviation)
Long Form:   endometrial cancer
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Comparison of serum human epididymis protein 4 and CA125 on endometrial cancer detection: A meta-analysis. DOR, HE4, NLR, PLR, SROC
2019 Sentinel Lymph Node Ultra-staging as a Supplement for Endometrial Cancer Intraoperative Frozen Section Deficiencies. IFS, SLN
2019 The impact of obesity and bariatric surgery on circulating and tissue biomarkers of endometrial cancer risk. AH
2018 A long noncoding RNAs signature to improve survival prediction in endometrioid endometrial cancer. EEC, lncRNAs
2018 A Non-invasive Liquid Biopsy Screening of Urine-Derived Exosomes for miRNAs as Biomarkers in Endometrial Cancer Patients. ---
2018 A novel preoperative scoring system based on 18-FDG PET-CT for predicting lymph node metastases in patients with high-risk endometrial cancer. FDG, LNm, PET-CT
2018 A Proposal for a Classification for Recurrent Endometrial Cancer: Analysis of a French Multicenter Database From the FRANCOGYN Study Group. CI, OS, RC, rL, rN
2018 A retrospective evaluation of the perioperative drug use and comparison of its cost in robotic vs open surgery for endometrial cancer. LOH, PACU
2018 A20-mediated deubiquitination of ERalpha in the microenvironment of CD163+ macrophages sensitizes endometrial cancer cells to estrogen. ---
10  2018 Accuracy of four mononucleotide-repeat markers for the identification of DNA mismatch-repair deficiency in solid tumors. CI, CRC, dMMR, dMSH6, MLH, MSH, MSI, pMMR, QMVR
11  2018 Adherence to Guidelines During Follow-up of Endometrial Cancer: Analysis of French Health Insurance Database. ---
12  2018 Adjuvant Treatment for POLE Proofreading Domain-Mutant Cancers: Sensitivity to Radiotherapy, Chemotherapy, and Nucleoside Analogues. mES
13  2018 Administration of Cabergoline Contributes to Preserving Fertility in Young Hyperprolactinemic Patients With Endometrial Cancer Treated With Medroxyprogesterone Acetate. MPA, noncabergoline group
14  2018 Advances in endometrial cancer protein biomarkers for use in the clinic. ---
15  2018 ALCAM shedding at the invasive front of the tumor is a marker of myometrial infiltration and promotes invasion in endometrioid endometrial cancer. ---
16  2018 Analysis of the circular RNA transcriptome in endometrial cancer. circRNAs
17  2018 Antidiabetic Medication, Statins and the Risk and Prognosis of Non-endometrioid Endometrial Cancer in Women with Type 2 Diabetes. ADM, CIs, HRs, T2D
18  2018 Assessing Estrogen-Induced Proliferative Response in an Endometrial Cancer Cell Line Using a Universally Applicable Methodological Guide. ---
19  2018 Association between tubal ligation and endometrial cancer risk: A Swedish population-based cohort study. HR, IR
20  2018 Association of Foxp3 promoter polymorphisms with susceptibility to endometrial cancer in the Chinese Han women. CI, OR
21  2018 Berberine suppresses growth and metastasis of endometrial cancer cells via miR-101/COX-2. AP-1, BBR, COX-2, PGE2
22  2018 Biomolecular basis related to inflammation in the pathogenesis of endometrial cancer. ---
23  2018 Blinded histopathological characterisation of POLE exonuclease domain-mutant endometrial cancers: sheep in wolf's clothing. ---
24  2018 Blocking 17beta-hydroxysteroid dehydrogenase type 1 in endometrial cancer: a potential novel endocrine therapeutic approach. CAM
25  2018 Blood Vessel Invasion in Endometrial Cancer Is One of the Mechanisms of Spread to the Cervix. CSI
26  2018 Cancer-associated fibroblasts induce epithelial-mesenchymal transition through secreted cytokines in endometrial cancer cells. CAFs, CM, EMT, NFs, RT-qPCR
27  2018 CD47 Blockade Inhibits Tumor Progression through Promoting Phagocytosis of Tumor Cells by M2 Polarized Macrophages in Endometrial Cancer. TAMs, TME
28  2018 Change in hazard rates of recurrence over time following diagnosis of endometrial cancer: An age stratified multicentre study from the FRANCOGYN group. HR
29  2018 Chemotherapy as Adjuvant Treatment for Early Stage Endometrial Cancer With High Intermediate Risk Factors. HIR
30  2018 Clinical impact of endometrial cancer stratified by genetic mutational profiles, POLE mutation, and microsatellite instability. IHC, MMR, MSI, PCR
31  2018 Clinical Outcome of Patients With High-Risk Endometrial Carcinoma After Treatment With Chemotherapy Only. ---
32  2018 Clinical significance of isolated tumor cells and micrometastasis in low-grade, stage I endometrial cancer. LVI, PFS
33  2018 Clinical significance of plasma anti-TOPO48 autoantibody and blood survivin-expressing circulating cancer cells in patients with early stage endometrial carcinoma. AAb, AUC, CCC, ELISA, ROC, RT-PCR-ELISA, TAA
34  2018 Clinicopathologic and survival results in serous endometrium carcinoma and subgroup analysis for mixed serous and pure serous histology. OS
35  2018 Clinicopathologic features of endometrial cancer in Chinese patients younger than 50 years with a family history of cancer. IHC, MMR, NFH, OR, PFH
36  2018 Comparison of Different Scoring Systems in the Assessment of Estrogen Receptor Status for Predicting Prognosis in Endometrial Cancer. ASCO/CAP, ER, HSCORE
37  2018 Comparison of Mayo and Milwaukee Risk Stratification Models for Predicting Lymph Node Metastasis in Endometrial Cancer. FNR
38  2018 Comparison of the prognostic value of different skeletal muscle radiodensity parameters in endometrial cancer. CT, HRSMI, LRSMI, SM, SMI
39  2018 Comparison Study of Laparoscopic Sentinel Lymph Node Mapping in Endometrial Carcinoma Using Carbon Nanoparticles and Lymphatic Pathway Verification. CNPs, IPP, SLN, UPP
40  2018 Computational development of a molecular-based approach to improve risk stratification of endometrial cancer patients. ---
41  2018 Conservative management of endometrial cancer: a survey amongst European clinicians. ENYGO
42  2018 Contribution of cervical cytology in the diagnostic work-up of patients with endometrial cancer. CI, OR, RFS
43  2018 Correlation Between Disease Stage and the Presence of Viable Circulating Tumor Cells in Endometrial Cancer. CTCs
44  2018 Cost-effectiveness analysis of biopsy strategies for endometrial cancer diagnosis in women with postmenopausal bleeding: Pipelle sampling curette versus dilatation & curettage. PMB
45  2018 Culture characters, genetic background, estrogen/progesterone receptor expression, and tumorigenic activities of frequently used sixteen endometrial cancer cell lines. ---
46  2018 Current landscape and future perspective of sentinel node mapping in endometrial cancer. ---
47  2018 Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Metastases from Endometrial Cancer. CC, CRS, HIPEC, OS, PCI, PFS
48  2018 Defining and mitigating the challenges of an older and obese population in minimally invasive gynecologic cancer surgery. ---
49  2018 Detection of endometrial cancer cells in the fallopian tube lumen is associated with adverse prognostic factors and reduced survival. age, race, CIs, HRs, ILTCs, LVSI, ORs, RFS
50  2018 Development of an Image-Guided Orthotopic Xenograft Mouse Model of Endometrial Cancer with Controllable Estrogen Exposure. BLI, CECT
51  2018 Disseminating universal genetic testing to a diverse, indigent patient population at a county hospital gynecologic oncology clinic. GC, GT, HGOC, IHC, UGTI
52  2018 Dosimetric comparison of vaginal vault brachytherapy vs applicator-guided stereotactic body radiotherapy with volumetric modulated arc therapy and helical tomotherapy for endometrium cancer patients. BRT, HDR, HT, OARs, PTV, VMAT
53  2018 Dysregulation of Kruppel-like factor 12 in the development of endometrial cancer. KLF12
54  2018 Effect of metformin use on the risk and prognosis of endometrial cancer: a systematic review and meta-analysis. CI, HR, OR
55  2018 Effects of Metformin on Cellular Proliferation and Steroid Hormone Receptors in Patient-Derived, Low-Grade Endometrial Cancer Cell Lines. ER, mTOR
56  2018 Efficacy of doxorubicin after progression on carboplatin and paclitaxel in advanced or recurrent endometrial cancer: a retrospective analysis of patients treated at the Brazilian National Cancer Institute (INCA). CT, OS, PFS
57  2018 Efficacy of liquid-based genetic diagnosis of endometrial cancer. LBC
58  2018 Endometrial cancer in the elderly: does age influence surgical treatments, outcomes, and prognosis? ---
59  2018 Endometrial cancer prognosis correlates with the expression of L1CAM and miR34a biomarkers. ---
60  2018 Endometrial cancer risk and survival by tumor MMR status. ANECS, CI, HR, MMR
61  2018 Enhancer of zeste homolog 2 blockade by RNA interference is implicated with inhibited proliferation, invasion and promoted apoptosis in endometrial carcinoma. EZH2
62  2018 ER and PR expression and survival after endometrial cancer. TMAs
63  2018 Estimating potential for savings for low risk endometrial cancer using the Endometrial Cancer Alternative Payment Model (ECAP): A companion paper to the Society of Gynecologic Oncology Report on the Endometrial Cancer Alternative Payment Model. ECAP, LOS
64  2018 Estradiol metabolites as biomarkers of endometrial cancer prognosis after surgery. HRs, MS, OS
65  2018 Estrogen and high-fat diet induced alterations in C57BL/6 mice endometrial transcriptome profile. HFD
66  2018 Estrogen related receptor alpha triggers the migration and invasion of endometrial cancer cells via up regulation of TGFB1. ERRalpha, TGF-beta
67  2018 Estrogen‑related receptorgamma promotes the migration and metastasis of endometrial cancer cells by targeting S100A4. ERRgamma, S100A4
68  2018 Evolution of adjuvant treatment in endometrial cancer-no evidence and new questions? EBRT, LSVI
69  2018 Exploration of DNA methylation markers for diagnosis and prognosis of patients with endometrial cancer. OS
70  2018 Expression and prognostic value of miRNA-29b in peripheral blood for endometrial cancer. ---
71  2018 Fertility-Sparing Management Using Progestin for Young Women with Endometrial Cancer From a Population-Based Study. CAH
72  2018 Folate receptor-alpha targeted near-infrared fluorescence imaging in high-risk endometrial cancer patients: a tissue microarray and clinical feasibility study. CRS, FRalpha, IHC, LN, TMA
73  2018 Frozen Section for Detection of Lymph Nodes After Cervical Injection with Indocyanine Green (ICG) for Sentinel Lymph Node Technique in Endometrial Cancer Staging. EN, FIGO, FS, ICG, SLN
74  2018 Galectin-7 is elevated in endometrioid (type I) endometrial cancer and promotes cell migration. ICAM-1, RT-qPCR
75  2018 Genetic variants in the microRNA machinery gene (Dicer) have a prognostic value in the management of endometrial cancer. SNP
76  2018 High TRIM44 expression in endometrial carcinoma is associated with a poorer patient outcome. FIGO, TRIM44
77  2018 HOTTIP regulates progression of endometrial cancer via activating PI3K/AKT pathway. ---
78  2018 Human epididymis protein 4 in endometrial cancer: A meta-analysis. AUC, DOR, HE4, NLR, PLR, SEN, SPE
79  2018 Human omental adipose-derived stem cells from donors with different body mass index had similar effects on proliferation and migration of endometrial cancer cells in vitro. O-ASC
80  2018 Hypoxia is involved in the reduction of HtrA3 in patients with endometrial hyperplasia and cancer. HtrA3, IHC
81  2018 Identification of Metabolomic Biomarkers for Endometrial Cancer and Its Recurrence after Surgery in Postmenopausal Women. NR
82  2018 Identification of micro-RNA expression profile related to recurrence in women with ESMO low-risk endometrial cancer. FFPE, LREC
83  2018 Illness perceptions are associated with higher health care use in survivors of endometrial cancer-a study from the population-based PROFILES registry. BIPQ
84  2018 Immunohistochemistry for mismatch repair protein deficiency in endometrioid endometrial carcinoma yields equivalent results when performed on endometrial biopsy/curettage or hysterectomy specimens. CAH, IHC, LS, MMRPs
85  2018 Impact of age at diagnosis on racial disparities in endometrial cancer patients. ---
86  2018 Impact of coexistent adenomyosis on outcomes of patients with endometrioid endometrial cancer: a propensity score-matched analysis. DFS, DSS, HR, OS
87  2018 Impact of endometriosis on risk of ovarian, endometrial and cervical cancers: a meta-analysis. CC, NOS, RR
88  2018 Impact of lymph node ratio on survival in stage IIIC endometrioid endometrial cancer: a Turkish Gynecologic Oncology Group study. CI, HR, LNR, LNs, OS, PFS
89  2018 Implementing the Risk of Endometrial Malignancy Algorithm (REM) adding obesity as a predictive factor: Results of REM-B in a single-center survey. BMI, REM, TS, VS
90  2018 Increased plasmatic soluble HLA-G levels in endometrial cancer. HLA-G, sHLA-G
91  2018 Independent predictors of survival in endometrium cancer: platelet-to-lymphocyte ratio and platelet/neutrophil/monocyte-to-lymphocyte ratio ---
92  2018 Independent psychometric validation of European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Endometrial Cancer Module (EORTC QLQ-EN24). ---
93  2018 Influence of YKL-40 gene RNA interference on the biological behaviors of endometrial cancer HEC-1A cells. FCM, si
94  2018 Integrated eicosanoid lipidomics and gene expression reveal decreased prostaglandin catabolism and increased 5-lipoxygenase expression in aggressive subtypes of endometrial cancer. 5-HETE, HPGD
95  2018 IR-A/IGF-1R-mediated signals promote epithelial-mesenchymal transition of endometrial carcinoma cells by activating PI3K/AKT and ERK pathways. EMT, IGF-1R, IR-A, PI3K
96  2018 Is there a benefit of lymphadenectomy for overall and recurrence-free survival in type I FIGO IB G1-2 endometrial carcinoma? A retrospective population-based cohort analysis. HR, LND, OAS, RFS
97  2018 Knowledge of the risk factors and symptoms associated with endometrial cancer in British South Asian and British White women. BSA, BW
98  2018 Laparoendoscopic Single-Site Sentinel Lymph Node Detection in Endometrial Cancer. LESS, SLN
99  2018 Life after endometrial cancer: A systematic review of patient-reported outcomes. BMI, PROs, QOL
100  2018 Lifetime number of years of menstruation as a risk index for postmenopausal endometrial cancer in the Norwegian Women and Cancer Study. LNYM, NOWAC